Product Code: GVR-4-68038-143-6
Wound Irrigation Systems Market Growth & Trends:
The global wound irrigation systems market size is expected to reach USD 411.57 million by 2030, registering a CAGR of 3.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The rising prevalence of chronic wounds, increasing number of surgical procedures, technological advancements, favorable initiatives taken by the private and public sectors, and the increasing cases of burns across the globe are the key factors driving the market.
A wound irrigation system allows rapid healing of deep wounds and surgical site infections. It also allows improved wound cleansing that prevents further complications. The increasing prevalence of chronic wounds and the rising number of surgical procedures are the key factors driving the market. For instance, as per a report published by ScienceDirect in 2018, the surgical infection has the highest prevalence rate of around 4.0%, followed by diabetic foot ulcers of around 3.4%. In addition, the rising number of wound care centers across the globe is expected to surge the demand for wound irrigation systems.
Moreover, the increasing incidence of burn cases across the globe is anticipated to boost the demand for the product. According to a report published by Walker Morgan, LLC, in 2017, around 450,000 Americans receive medical treatment for burn injuries every year. As per the report published by Swift Medical Inc. in 2018, more than 305.0 million acute, burn, and traumatic wounds are recorded per year globally. Furthermore, as per the data reported by the WHO, over 1,000,000 people register, annually, as moderately or severely burnt. As wound irrigation system is very much effective in burn injury and allows rapid healing, thus increasing incidence rate of burns is anticipated to propel the market growth over the forecast period.
Wound Irrigation Systems Market Report Highlights:
- By product, the manual wound irrigation system segment held the largest market share of 55.3% in 2022 owing to the increasing incidence of burns and surgical site infection across the globe
- Based on application, the chronic wounds segment held the largest revenue share of around 30.0% in 2022 due to the rising prevalence of diabetic foot ulcers and pressure ulcers
- Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising number of diabetic patients in this region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Wound Irrigation Systems Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Increasing incidence of chronic diseases
- 3.3.1.2. Rising geriatric population
- 3.3.1.3. Increasing number of procedures
- 3.3.2. Market restraint analysis
- 3.3.2.1. Lack of skilled professionals in developing and underdeveloped countries
- 3.4. Wound Irrigation Systems Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Wound Irrigation System: Product Estimates & Trend Analysis
- 4.1. Wound Irrigation Systems Market: Key Takeaways
- 4.2. Wound Irrigation Systems Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Manual
- 4.3.1. Manual market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Battery-operated
- 4.4.1. Battery-operated market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Wound Irrigation System: Application Estimates & Trend Analysis
- 5.1. Wound Irrigation Systems Market: Key Takeaways
- 5.2. Wound Irrigation Systems Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Chronic Wounds
- 5.3.1. Chronic wounds market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Diabetic Foot Ulcer
- 5.4.1. Diabetic foot ulcer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Pressure Ulcer
- 5.5.1. Pressure ulcer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Venous Leg Ulcers
- 5.6.1. Venous leg ulcers market, 2018 to 2030 (USD Million)
- 5.7. Burns
- 5.7.1. Burns market 2018 to 2030 (USD Million)
- 5.8. Surgical Wounds
- 5.8.1. Surgical wounds market 2018 to 2030 (USD Million)
- 5.9. Traumatic Wounds
- 5.9.1. Traumatic wounds market 2018 to 2030 (USD Million)
Chapter 6. Wound Irrigation Systems Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Wound Irrigation Systems Market by Region: Key Marketplace Takeaway
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Zimmer Biomet
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Stryker Corporation
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Centurion Medical Products
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. BSN Medica
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Cooper Surgical Inc
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. C. R. Bard, Inc
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Bionix
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Westmed, Inc
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives